<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="correction"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Support Care Cancer</journal-id><journal-id journal-id-type="iso-abbrev">Support Care Cancer</journal-id><journal-title-group><journal-title>Supportive Care in Cancer</journal-title></journal-title-group><issn pub-type="ppub">0941-4355</issn><issn pub-type="epub">1433-7339</issn><publisher><publisher-name>Springer Berlin Heidelberg</publisher-name><publisher-loc>Berlin/Heidelberg</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">26542273</article-id><article-id pub-id-type="pmc">4714018</article-id><article-id pub-id-type="publisher-id">3003</article-id><article-id pub-id-type="doi">10.1007/s00520-015-3003-3</article-id><article-categories><subj-group subj-group-type="heading"><subject>Erratum</subject></subj-group></article-categories><title-group><article-title>Erratum to: Elemental diet plus glutamine for the prevention of mucositis in esophageal cancer patients receiving chemotherapy: a feasibility study</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Tanaka</surname><given-names>Yoshihiro</given-names></name><address><email>yoshihirotana11@hotmail.com</email></address><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author"><name><surname>Takahashi</surname><given-names>Takao</given-names></name><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author"><name><surname>Yamaguchi</surname><given-names>Kazuya</given-names></name><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author"><name><surname>Osada</surname><given-names>Shinji</given-names></name><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author"><name><surname>Shimokawa</surname><given-names>Toshio</given-names></name><xref ref-type="aff" rid="Aff2"/></contrib><contrib contrib-type="author"><name><surname>Yoshida</surname><given-names>Kazuhiro</given-names></name><xref ref-type="aff" rid="Aff1"/></contrib><aff id="Aff1"><label/>Department of Surgical Oncology, Gifu Graduate School of Medicine, 1-1 Yanagido, Gifu City, Gifu 501-1194 Japan </aff><aff id="Aff2"><label/>Graduate School of Medicine and Engineering, University of Yamanashi, 4-4-37 Takeda, Kofu City, 400-8510 Japan </aff></contrib-group><pub-date pub-type="epub"><day>5</day><month>11</month><year>2015</year></pub-date><pub-date pub-type="ppub"><year>2016</year></pub-date><volume>24</volume><fpage>943</fpage><lpage>943</lpage><permissions><copyright-statement>&#x000a9; Springer-Verlag Berlin Heidelberg 2015</copyright-statement></permissions><related-article related-article-type="corrected-article" id="d30e89" ext-link-type="doi" xlink:href="10.1007/s00520-015-2864-9"/><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; Springer-Verlag Berlin Heidelberg 2016</meta-value></custom-meta></custom-meta-group></article-meta></front><body><p><bold>Erratum to: Support Care Cancer</bold></p><p><bold>DOI 10.1007/s00520-015-2864-9</bold></p><p>Table <xref rid="Tab2" ref-type="table">2</xref>. The number of patients in Gln and Gln plus ED should be corrected.</p><p><bold>This is the correct Table</bold><xref rid="Tab2" ref-type="table">2</xref><bold>. </bold><table-wrap id="Tab2"><label>Table 2</label><caption><p>Multivariate analysis for independent factors affecting increased mucositis grade during chemotherapy</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Factor</th><th/><th>
<italic>n</italic>
</th><th>Odds ratio (95&#x000a0;% CI)</th><th>
<italic>P</italic> value</th><th>Odds ratio (95&#x000a0;% CI)</th><th>
<italic>P</italic> value</th></tr></thead><tbody><tr><td>Gln</td><td>With</td><td>10</td><td>4.1 (0.6&#x02013;33.7)</td><td>0.17</td><td>4.0 (0.7&#x02013;29.6)</td><td>0.15</td></tr><tr><td/><td>Without</td><td>20</td><td/><td/><td/><td/></tr><tr><td>Gln plus ED</td><td>With</td><td>10</td><td>0.1 (0.0&#x02013;0.7)</td><td>0.03*</td><td>0.1 (0.0&#x02013;0.6)</td><td>0.02*</td></tr><tr><td/><td>Without</td><td>20</td><td/><td/><td/><td/></tr><tr><td>Age, years</td><td>&#x0003c;70</td><td>16</td><td>3.1 (0.7&#x02013;16.5)</td><td>0.16</td><td>3.1 (0.7&#x02013;16.1)</td><td>0.15</td></tr><tr><td/><td>&#x02265;70</td><td>14</td><td/><td/><td/><td/></tr><tr><td>Sex</td><td>Male</td><td>26</td><td>0.9 (0.1&#x02013;7.7)</td><td>0.95</td><td>&#x02013;</td><td>&#x02013;</td></tr><tr><td/><td>Female</td><td>4</td><td/><td/><td/><td/></tr><tr><td>Cancer stage</td><td>IVa,b</td><td>13</td><td>14.6 (1.9&#x02013;150.0)</td><td>0.01*</td><td>13.3 (1.9&#x02013;123.2)</td><td>0.01*</td></tr><tr><td/><td>II&#x02013;III</td><td>17</td><td/><td/><td/><td/></tr><tr><td>Treatment</td><td>First-line</td><td>7</td><td>0.2 (0.0&#x02013;2.1)</td><td>0.19</td><td>0.2 (0.0&#x02013;1.6)</td><td>0.13</td></tr><tr><td/><td>NAC</td><td>23</td><td/><td/><td/><td/></tr><tr><td>BMI</td><td>&#x0003c;21</td><td>13</td><td>1.9 (0.4&#x02013;9.6)</td><td>0.44</td><td>&#x02013;</td><td>&#x02013;</td></tr><tr><td/><td>&#x02265;21</td><td>17</td><td/><td/><td/><td/></tr></tbody></table><table-wrap-foot><p>
<italic>BMI</italic> body mass index, <italic>ED</italic> elemental diet, <italic>Gln</italic> glutamine, <italic>NAC</italic> neoadjuvant chemotherapy</p><p>*<italic>p</italic>&#x02009;&#x0003c;&#x02009;<italic>0.05</italic>
</p></table-wrap-foot></table-wrap></p></body></article>